From Wikipedia, the free encyclopedia
Sir Ravinder Nath Maini
Sir Ravinder N. Maini in Budapest, 2013.
|Alma mater||Sidney Sussex College, Cambridge|
|Known for||discovery of anti-TNF therapy as an effective treatment for rheumatoid arthritis|
|Awards||Crafoord Prize (2000)|
Albert Lasker Award for Clinical Medical Research (2003)
Dr. Paul Janssen Award for Biomedical Research (2008)
Gairdner Foundation International Award (2014)
|Institutions||Imperial College School of Medicine|
Maini was born in Ludhiana, Punjab, British India, to Sir Amar Maini, a Kenyan-born lawyer and Ugandan politician, and his wife, Sam Saheli Mehra. His younger brother is academic Yoginder Nath Tidu Maini. Ravinder completed his bachelor's degree at Sidney Sussex College, Cambridge. In the 1980s, Maini and colleague Marc Feldmann identified TNF alpha as a key cytokine in the process of rheumatoid arthritis.
- 2000: Maini was awarded the Crafoord Prize.
- 2003: Knighthood
- 2003: Albert Lasker Award for Clinical Medical Research.
- 2004 Fothergillian prize from the London Medical Society 
- 2007 Elected Fellow of the Royal Society 
- 2008: Dr. Paul Janssen Award for Biomedical Research together with Marc Feldmann.
- 2010 Ernst Schering Prize from the German Schering Foundation together with Marc Feldmann.
- Mosley, Charles, ed. (2003). Burke's Peerage, Baronetage & Knighthood (107 ed.). Burke's Peerage & Gentry. p. 2562. ISBN 0-9711966-2-1.
- "The Crafoord Prize 2000".
- "Imperial College London - British Scientists receive Lasker Prize for discovering new treatment for rheumatoid arthritis". www.imperial.ac.uk.
- "Sir Ravinder Maini - F1000Prime". f1000.com.
- "Ravinder Maini-Biography". Royal Society. Retrieved 26 January 2017.
- "Dr. Paul Janssen Award". Dr. Paul Janssen Award.
- Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research Archived 2010-01-29 at the Wayback Machine
- "Schering Stiftung".
- "Honorary members - British Society for Immunology". www.immunology.org.
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.